Option Care Health, Inc. (NASDAQ:OPCH) Given Average Recommendation of "Moderate Buy" by Brokerages

Key Points

• Consensus: Moderate Buy — Twelve analyst firms rate OPCH a "Moderate Buy" with an average 1‑year target of about $31.25, though recent price targets have varied and some firms have trimmed estimates.
• Mixed Q1 and legal risk — Q1 EPS modestly beat ($0.40 vs. $0.37) but revenue missed ($1.35B vs. $1.39B) and management trimmed guidance, triggering multiple securities‑fraud investigations and shareholder class‑action solicitations that elevate execution and legal risk.
• Insider accumulation — Company insiders (including two directors and the CEO) purchased roughly 73,264 shares (~$1.55M) recently, signaling management confidence despite the recent selloff.

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $31.25.

A number of research analysts have weighed in on OPCH shares. National Bank Financial set a $37.00 price objective on shares of Option Care Health in a research report on Tuesday, January 27th. JPMorgan Chase & Co. decreased their price objective on shares of Option Care Health from $40.00 to $33.00 and set an "overweight" rating for the company in a research report on Monday. Morgan Stanley set a $28.00 price objective on shares of Option Care Health in a research report on Wednesday. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, UBS Group decreased their price objective on shares of Option Care Health from $45.00 to $39.00 and set a "buy" rating for the company in a research report on Friday, May 1st.

Option Care Health Trading Up 1.5%

NASDAQ OPCH opened at $20.75 on Friday. The company has a market capitalization of $3.26 billion, a PE ratio of 16.09, a P/E/G ratio of 1.10 and a beta of 0.68. The company has a fifty day moving average of $28.29 and a 200 day moving average of $30.61. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.03. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The firm's quarterly revenue was up 1.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Research analysts forecast that Option Care Health will post 1.69 earnings per share for the current year.

Key Option Care Health News

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Two directors made sizeable purchases, increasing insider ownership and signaling management confidence — Timothy P. Sullivan bought 24,154 shares at ~$20.69 (May 7). Sullivan SEC Filing
• Positive Sentiment: Director Harry Jansen Kraemer Jr. purchased 36,610 shares at ~$21.41 (May 4), further highlighting insider accumulation. Kraemer SEC Filing
• Neutral Sentiment: Morgan Stanley reaffirmed an "Overweight" rating (institutional support remains), and other analysts show a split view — Consensus remains a "Moderate Buy" with an average target around $32, but recent price targets vary. Analyst Coverage
• Neutral Sentiment: Management will speak at the Bank of America Health Care Conference (May 12), which could be a catalyst for clarification on execution and outlook. Conference Notice
• Negative Sentiment: Multiple securities‑fraud investigations and shareholder class‑action solicitations were launched after the April 30 Q1 report and a subsequent revenue/guidance revision — this raises potential legal, financial and reputational risk that could pressure the stock. Representative notices: Levi & Korsinsky, Holzer & Holzer, Block & Leviton and others. Holzer Alert Block & Leviton
• Negative Sentiment: Q1 fundamentals were mixed: EPS beat modestly ($0.40 vs. $0.37) but revenue missed (~$1.35B vs. ~$1.39B) and management trimmed full‑year revenue/earnings outlooks, prompting a sharp prior selloff and heightened execution concerns. Earnings & Guidance

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of the firm's stock in a transaction on Monday, May 4th. The stock was acquired at an average price of $21.41 per share, for a total transaction of $783,820.10. Following the completion of the transaction, the director owned 450,000 shares in the company, valued at approximately $9,634,500. The trade was a 8.86% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John Charles Rademacher bought 12,500 shares of the business's stock in a transaction dated Monday, May 4th. The shares were bought at an average cost of $21.18 per share, with a total value of $264,750.00. Following the purchase, the chief executive officer directly owned 695,152 shares of the company's stock, valued at approximately $14,723,319.36. This represents a 1.83% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders bought 73,264 shares of company stock worth $1,548,316. Company insiders own 1.70% of the company's stock.

Institutional Trading of Option Care Health

Institutional investors and hedge funds have recently modified their holdings of the stock. V Square Quantitative Management LLC purchased a new stake in shares of Option Care Health during the fourth quarter worth about $25,000. Cornerstone Planning Group LLC increased its stake in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company's stock worth $30,000 after purchasing an additional 1,067 shares in the last quarter. McIlrath & Eck LLC purchased a new stake in shares of Option Care Health during the second quarter worth about $37,000. Advisory Services Network LLC purchased a new stake in shares of Option Care Health during the third quarter worth about $35,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Option Care Health during the third quarter worth about $38,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Company Profile

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.